Sugi Predict

Sugi Predict / Compounds / SCHEMBL28858829

SCHEMBL28858829

SCHEMBL28858829

CS(=O)(=O)On1cnc2cncnc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 1/20 0.38
▸ CYP1A2 P05177 13/20 0.36
▸ CYP3A4 P08684 12/20 0.36
▸ HSD17B10 Q99714 4/20 0.36
▸ TSHR P16473 8/20 0.35
▸ CLK4 Q9HAZ1 4/20 0.35
▸ USP2 O75604 8/20 0.34
▸ ALDH1A1 P00352 8/20 0.34
▸ CYP2C19 P33261 7/20 0.34
▸ CYP2C9 P11712 6/20 0.34
▸ LMNA P02545 4/20 0.34
▸ CYP2D6 P10635 3/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ MAPK1 P28482 2/20 0.33
▸ LTA4H P09960 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1398869 0.79 FDPS (0.41) FDPSCYP1A2CYP3A4HSD17B10TSHR
SCHEMBL7626872 0.77 FDPS (0.41) FDPSCYP1A2CYP3A4HSD17B10TSHR
SCHEMBL13281305 0.77 FDPS (0.41) FDPSCYP1A2CYP3A4HSD17B10TSHR
SCHEMBL28123586 0.75 KDM4E (0.41) HSD17B10ALDH1A1HDAC6
SCHEMBL4421419 0.75 FDPS (0.41) FDPSCYP1A2CYP3A4HSD17B10TSHR
SCHEMBL788097 0.75 FDPS (0.41) FDPSCYP1A2CYP3A4HSD17B10TSHR
SCHEMBL2894577 0.73 FDPS (0.40) FDPSCYP1A2CYP3A4HSD17B10TSHR
SCHEMBL1443067 0.73 FDPS (0.40) FDPSCYP1A2CYP3A4HSD17B10TSHR
SCHEMBL28139068 0.71 LTA4H (0.44) FDPSCYP1A2CYP3A4HSD17B10TSHR
SCHEMBL5989432 0.71 FDPS (0.51) FDPSCYP1A2CYP3A4HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570657-B2 Mesylate salts of heterocyclic cytokinins, compositions containing these derivatives and use thereof UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2026-03-10 — — US disclosed
US-20230192697-A1 MESYLATE SALTS OF HETEROCYCLIC CYTOKININS, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2023-06-22 — — US disclosed
EP-4153592-A1 MESYLATE SALTS OF HETEROCYCLIC CYTOKININS, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF Univerzita Palackého v Olomouci (CZ) 2023-03-29 — — EP disclosed
CN-107892691-A 2,8,9 3 substitution 9H purine compounds and its salt and application 西安交通大学 2018-04-10 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192697-A1 MESYLATE SALTS OF HETEROCYCLIC CYTOKININS, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF MAT1A, MAT2A, MAT2B FDPS 370/4885CYP1A2 2544/4885CYP3A4 2734/4885
US-12570657-B2 Mesylate salts of heterocyclic cytokinins, compositions containing these derivatives and use thereof TYMP, TK1, DCK FDPS 881/4885CYP1A2 610/4885CYP3A4 1536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.